Chairs: Rajesh Thakker & Hanh Nguyen
Living with hypoparathyroidism and working together to overcome it (#229)
8:30 AM
Calcilytics for the Treatment of Individuals with Autosomal Dominant Hypocalcemia Type 1 (ADH1) (#230)
8:50 AM
The safety and efficacy of eneboparatide, a parathyroid hormone 1 receptor agonist, in adults with chronic hypoparathyroidism: a phase 3, randomized, placebo-controlled study (CALYPSO) (#231)
9:20 AM
Outcome of Phase-2 trial of Canvuparatide for Hypoparathyroidism (#232)
9:50 AM
10.10 Aliya Khan: Trial outcomes and clinical experience with Palopegteriparatide (recorded presentation)